Purple Biotech (XTAE:PPBT) Short-Term Capital Lease Obligation : ₪0.70 Mil (As of Mar. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Short-Term Capital Lease Obligation?

Purple Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₪0.70 Mil.

Purple Biotech's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₪0.67 Mil) to Dec. 2023 (₪0.70 Mil) but then declined from Dec. 2023 (₪0.70 Mil) to Mar. 2024 (₪0.70 Mil).

Purple Biotech's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₪0.75 Mil) to Dec. 2022 (₪0.73 Mil) and declined from Dec. 2022 (₪0.73 Mil) to Dec. 2023 (₪0.70 Mil).

Purple Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Purple Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Short-Term Capital Lease Obligation Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.73

0.78

0.75

0.73

0.70

Purple Biotech Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.71	0.69	0.67	0.70	0.70

Purple Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Purple Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.